These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
133 related articles for article (PubMed ID: 20938822)
61. Long-term risk of progression of carcinoma in situ of the bladder and impact of bacille Calmette-Guérin immunotherapy on the outcome. Zieger K; Jensen KM Scand J Urol Nephrol; 2011 Dec; 45(6):411-8. PubMed ID: 21793636 [TBL] [Abstract][Full Text] [Related]
62. A second look at the pT1 G3 bladder tumour. Harland SJ Clin Oncol (R Coll Radiol); 2005 Oct; 17(7):498-502. PubMed ID: 16238136 [TBL] [Abstract][Full Text] [Related]
63. EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder, the 2011 update. Babjuk M; Oosterlinck W; Sylvester R; Kaasinen E; Böhle A; Palou-Redorta J; Rouprêt M; Eur Urol; 2011 Jun; 59(6):997-1008. PubMed ID: 21458150 [TBL] [Abstract][Full Text] [Related]
64. [Management of Ta, T1, and in situ bladder carcinoma: what is new?]. Irani J Prog Urol; 2008 May; 18 Suppl 5():S94-8. PubMed ID: 18585634 [TBL] [Abstract][Full Text] [Related]
65. Chlorin e6-polyvinylpyrrolidone mediated photodynamic therapy--A potential bladder sparing option for high risk non-muscle invasive bladder cancer. Lee LS; Thong PS; Olivo M; Chin WW; Ramaswamy B; Kho KW; Lim PL; Lau WK Photodiagnosis Photodyn Ther; 2010 Dec; 7(4):213-20. PubMed ID: 21112542 [TBL] [Abstract][Full Text] [Related]
67. Intravesical treatment of severe bacillus Calmette-Guerin cystitis. Palou J; Rodríguez-Villamil L; Andreu-Crespo A; Salvador-Bayarri J; Vicente-Rodríguez J Int Urol Nephrol; 2001; 33(3):485-9. PubMed ID: 12230277 [TBL] [Abstract][Full Text] [Related]
68. The efficacy of intravesical bacillus Calmette-Guerin in the treatment of patients with pT1 stage non-muscle-invasive bladder cancer. Ajili F; Darouiche A; Chebil M; Boubaker S Ultrastruct Pathol; 2013 Aug; 37(4):278-83. PubMed ID: 23789613 [TBL] [Abstract][Full Text] [Related]
69. [International Consensus Panel--treatment strategies for superficial bladder cancer]. Adler S; St Niclas M Aktuelle Urol; 2006 Sep; 37(5):320-3; discussion 322-3. PubMed ID: 17004179 [No Abstract] [Full Text] [Related]
70. Radical cystectomy for BCG failure: has the timing improved in recent years? Soloway MS; Hepps D; Katkoori D; Ayyathurai R; Manoharan M BJU Int; 2011 Jul; 108(2):182-5. PubMed ID: 21070578 [TBL] [Abstract][Full Text] [Related]
71. The combination cytology/epichek test in non muscle invasive bladder carcinoma follow-up: Effective tool or useless expence? Pierconti F; Martini M; Fiorentino V; Cenci T; Capodimonti S; Straccia P; Sacco E; Pugliese D; Cindolo L; Larocca LM; Bassi PF Urol Oncol; 2021 Feb; 39(2):131.e17-131.e21. PubMed ID: 32773233 [TBL] [Abstract][Full Text] [Related]
72. Recurrence and progression of stage T1, grade 3 transitional cell carcinoma of the bladder following intravesical immunotherapy with bacillus Calmette-Guerin. Brake M; Loertzer H; Horsch R; Keller H J Urol; 2000 Jun; 163(6):1697-701. PubMed ID: 10799163 [TBL] [Abstract][Full Text] [Related]